Guadecitabine With or Without Idarubicin or Cladribine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Condition(s):Untreated Adult Acute Myeloid LeukemiaLast Updated:October 16, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Untreated Adult Acute Myeloid LeukemiaLast Updated:October 16, 2023Completed
Condition(s):Untreated Adult Acute Myeloid LeukemiaLast Updated:November 29, 2023Recruiting
Condition(s):Untreated Adult Acute Myeloid LeukemiaLast Updated:June 30, 2022Completed
Condition(s):Untreated Adult Acute Myeloid LeukemiaLast Updated:May 31, 2023Completed
Condition(s):Untreated Adult Acute Myeloid LeukemiaLast Updated:July 3, 2018Withdrawn
Condition(s):Acute Myeloid Leukemia; Untreated Adult Acute Myeloid LeukemiaLast Updated:December 19, 2018Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:August 30, 2023Completed
Condition(s):Recurrent Adult Acute Myeloid Leukemia; Untreated Adult Acute Myeloid LeukemiaLast Updated:April 6, 2018Terminated
Condition(s):Chronic Myeloid Leukemia in Myeloid Blast Crisis; Untreated Adult Acute Myeloid LeukemiaLast Updated:May 11, 2016Unknown status
Condition(s):Recurrent Adult Acute Myeloid Leukemia; Untreated Adult Acute Myeloid LeukemiaLast Updated:October 20, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.